4.7 Article

One-step scalable preparation method for non-cationic liposomes with high siRNA content

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 490, Issue 1-2, Pages 316-323

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2015.05.072

Keywords

Calcium ion; Drug delivery; Encapsulation; Ethanol; Liposomes; siRNA

Funding

  1. KAKENHI [25242043, 25870310, 25003835]
  2. Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN)
  3. Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare
  4. Grants-in-Aid for Scientific Research [25242043, 15K21068, 13J03835, 25870310] Funding Source: KAKEN

Ask authors/readers for more resources

Cationic liposomes (LPs) have been utilized for short interfering RNA (siRNA) delivery in vitro and in vivo owing to their high affinity for siRNA via electrostatic binding. However, both cytotoxicity and nonspecific adsorption of cationic LPs in the body have prevented clinical siRNA applications. These situations have led to siRNA encapsulation in non-cationic LPs. We found that the instillation of neutral phospholipids dissolved in ethanol into aqueous solutions containing siRNA and CaCl2 resulted in high siRNA encapsulation (siRNA encapsulation efficiency: similar to 80%; siRNA weight ratio: similar to 10 wt% of LPs). The products were monodispersed, similar to 200 nm, and negatively charged. Furthermore, when phospholipids with a high-phase transition temperature or cholesterol were used, the encapsulation efficiency and siRNA content remained high. Although anionic LPs could not encapsulate siRNAs using this method, the use of cholesterol-conjugated siRNA helped achieve substantial siRNA encapsulation in anionic LPs. These non-cationic siRNA-containing LPs did not show cytotoxicity in vitro, and could be formed with polyethylene glycol-conjugated phospholipids. When conjugated with targeting ligand, the non-cationic siRNA-containing LPs could suppress the expression of target gene in vitro. These data demonstrate that our preparation method would be suitable for large-scale LP production for systemic siRNA delivery. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available